Literature DB >> 18932283

Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model.

Tatsuhiro Tsujimoto1, Hideto Kawaratani, Toshiyuki Kitazawa, Toshiko Hirai, Hajime Ohishi, Mitsuteru Kitade, Hitoshi Yoshiji, Masahito Uemura, Hiroshi Fukui.   

Abstract

AIM: To investigate Kupffer cell dynamics and phagocytic activity, using a rat nonalcoholic steatohepatitis (NASH) model.
METHODS: Male F344 rats were fed either a control diet or a choline-deficient L-amino acid-defined (CDAA) diet, followed by contrast enhanced ultrasonography (CEUS) using Levovist. The uptake of latex beads by the Kupffer cells was determined by fluorescent microscopy. The status of the Kupffer cells was compared between the two groups, using the immunohistochemical staining technique.
RESULTS: After 4 or more wk of the CDAA diet, CEUS examination revealed a decrease in the signal intensity, 20 min after intravenous Levovist. Fluorescent microscopic examination showed that the uptake of latex beads by the Kupffer cells was reduced at week 1 and 2 in the study group, compared with the controls, with no further reduction after 3 wk. Immunohistochemical staining revealed no significant difference in the Kupffer cell counts between the control group and the CDAA group.
CONCLUSION: CEUS examination using Levovist demonstrated reduced contrast effect and phagocytic activity in the liver parenchymal phase, although the Kupffer cell numbers were unchanged, indicating reduced phagocytic function of the Kupffer cells in the rat NASH model. We believe that CEUS examination using Levovist is a useful screening modality, which can detect NASH in fatty liver patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18932283      PMCID: PMC2760201          DOI: 10.3748/wjg.14.6036

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers.

Authors:  T Tsujimoto; S Kuriyama; M Yamazaki; Y Nakatani; H Okuda; H Yoshiji; H Fukui
Journal:  Int J Oncol       Date:  2001-01       Impact factor: 5.650

2.  Initial observations on the effect of irradiation on the liver-specific uptake of Levovist.

Authors:  Emilio Quaia; Martin J K Blomley; Shetal Patel; Christopher J Harvey; Anwar Padhani; Pat Price; David O Cosgrove
Journal:  Eur J Radiol       Date:  2002-03       Impact factor: 3.528

3.  Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.

Authors:  Kyosuke Yanagisawa; Fuminori Moriyasu; Takeo Miyahara; Miyata Yuki; Hiroko Iijima
Journal:  Ultrasound Med Biol       Date:  2007-02       Impact factor: 2.998

4.  Disposition of perfluorobutane in rats after intravenous injection of Sonazoid.

Authors:  Kim Gunnar Toft; Svein Olaf Hustvedt; Petter-Arnt Hals; Inger Oulie; Steinar Uran; Kristin Landmark; Per Trygve Normann; Tore Skotland
Journal:  Ultrasound Med Biol       Date:  2006-01       Impact factor: 2.998

5.  Choline deficiency augments and antibody to tumor necrosis factor-alpha attenuates endotoxin-induced hepatic injury.

Authors:  C E Eastin; C J McClain; E Y Lee; G J Bagby; R K Chawla
Journal:  Alcohol Clin Exp Res       Date:  1997-09       Impact factor: 3.455

6.  Stimulation of phagocytic activity of murine Kupffer cells by tuftsin.

Authors:  S Kubo; T Rodriguez; M S Roh; C Oyedeji; M M Romsdahl; K Nishioka
Journal:  Hepatology       Date:  1994-04       Impact factor: 17.425

7.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

8.  Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.

Authors:  Y Zen; K Katayanagi; K Tsuneyama; K Harada; I Araki; Y Nakanuma
Journal:  Pathol Int       Date:  2001-02       Impact factor: 2.534

9.  Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis.

Authors:  Hiroko Iijima; Fuminori Moriyasu; Kaoru Tsuchiya; Shiro Suzuki; Masahiro Yoshida; Masafumi Shimizu; Shunichi Sasaki; Syuhei Nishiguchi; Shiro Maeyama
Journal:  Hepatol Res       Date:  2007-06-07       Impact factor: 4.288

10.  Local ablation procedures in primary liver tumors: Levovist US versus spiral CTto evaluate therapeutic results.

Authors:  Paolo Vallone; Adolfo Gallipoli; Francesco Izzo; Francesco Fiore; Paolo Delrio
Journal:  Anticancer Res       Date:  2003 Nov-Dec       Impact factor: 2.480

View more
  17 in total

1.  A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma.

Authors:  Masato Fujii; Yuichiro Shibazaki; Kyoko Wakamatsu; Yutaka Honda; Yusuke Kawauchi; Kenji Suzuki; Somasundaram Arumugam; Kenichi Watanabe; Takafumi Ichida; Hitoshi Asakura; Hiroyuki Yoneyama
Journal:  Med Mol Morphol       Date:  2013-02-22       Impact factor: 2.309

2.  Innate immune reactivity of the ileum-liver axis in nonalcoholic steatohepatitis.

Authors:  Tatsuhiro Tsujimoto; Hideto Kawaratani; Toshiyuki Kitazawa; Masahito Uemura; Hiroshi Fukui
Journal:  Dig Dis Sci       Date:  2012-02-25       Impact factor: 3.199

3.  Fatty liver is associated with recurrent bacterial infections independent of metabolic syndrome.

Authors:  William Nseir; Hussein Taha; Julnar Khateeb; Maria Grosovski; Nimer Assy
Journal:  Dig Dis Sci       Date:  2011-05-12       Impact factor: 3.199

4.  Correlation of Kupffer cell function and hepatocyte function in chronic viral hepatitis evaluated with superparamagnetic iron oxide-enhanced magnetic resonance imaging and scintigraphy using technetium-99m-labelled galactosyl human serum albumin.

Authors:  Tatsuyuki Tonan; Kiminori Fujimoto; Aliya Qayyum; Sanae Azuma; Masatoshi Ishibashi; Takato Ueno; Noriyuki Ono; Junji Akiyoshi; Sunao Matsushita; Naofumi Hayabuchi; Takumi Kawaguchi; Michio Sata
Journal:  Exp Ther Med       Date:  2011-04-11       Impact factor: 2.447

5.  Effects of glycine on phagocytosis and secretion by Kupffer cells in vitro.

Authors:  Hui-Wen Wu; Ke-Ming Yun; De-Wu Han; Rui-Ling Xu; Yuan-Chang Zhao
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

Review 6.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

7.  Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice.

Authors:  Hiroko Itagaki; Kazuhiko Shimizu; Shunichi Morikawa; Kenji Ogawa; Taichi Ezaki
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

8.  Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138.

Authors:  Tatsuhiro Tsujimoto; Hideto Kawaratani; Toshiyuki Kitazawa; Hitoshi Yoshiji; Masao Fujimoto; Masahito Uemura; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

9.  Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis.

Authors:  Hitoshi Yoshiji; Ryuichi Noguchi; Tadashi Namisaki; Kei Moriya; Mitsuteru Kitade; Yosuke Aihara; Akitoshi Douhara; Hideto Kawaratani; Norihisa Nishimura; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2013-11-07       Impact factor: 7.527

10.  Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet.

Authors:  Hideto Kawaratani; Tatsuhiro Tsujimoto; Toshiyuki Kitazawa; Mitsuteru Kitade; Hitoshi Yoshiji; Masahito Uemura; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.